cilostazol has been researched along with Cardiometabolic Syndrome in 2 studies
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We review what we consider to be the top 12 advances in this field: the discovery of nitric oxide, the metabolic syndrome, new thrombophilic disorders, therapeutic angiogenesis, endoluminal treatment of chronic venous disease, and a variety of drugs, including sildenafil, cilostazol, low-molecular-weight heparins, oral direct thrombin inhibitors, clopidogrel, statins, and angiotensin-converting enzyme inhibitors and angiotensin-receptor blocking agents." | 4.82 | The top 12 advances in vascular medicine. ( Beckman, JA; Jaff, MR; Jang, J; Olin, JW; Rooke, T, 2004) |
| "The key areas of treatment focus on smoking cessation, exercise rehabilitation, with supervised therapy if possible, cardiovascular risk prevention with antiplatelet drugs, statins and angiotensin converting enzymes, and correction of atherosclerotic risk factors with well-defined targets (LDL less than 1g/L, HDL greater than 0." | 2.45 | [Peripheral arterial disease with lower limb claudication: Medical treatment]. ( Bui, HT; Hadj Henni, A; Journet, J; Long, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Long, A | 1 |
| Bui, HT | 1 |
| Journet, J | 1 |
| Hadj Henni, A | 1 |
| Olin, JW | 1 |
| Jang, J | 1 |
| Jaff, MR | 1 |
| Beckman, JA | 1 |
| Rooke, T | 1 |
2 reviews available for cilostazol and Cardiometabolic Syndrome
| Article | Year |
|---|---|
[Peripheral arterial disease with lower limb claudication: Medical treatment].
Topics: Aged; Antihypertensive Agents; Arteriosclerosis; Cilostazol; Comorbidity; Diabetes Complications; Dr | 2009 |
The top 12 advances in vascular medicine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cilostazol; Clopidogrel; Factor V; Heparin, Low-Molecular- | 2004 |